Citigroup Initiates Coverage of Arrowhead Pharmaceuticals (ARWR) with Neutral Recommendation
19/9 20:05
Fintel reports that on September 19, 2023, Citigroup initiated coverage of Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Neutral recommendation. Analyst Price Forecast Suggests 112.26% Upside...